 | • レポートコード：QFJ1-4584 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、非侵襲的大腸がんスクリーニングの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（糞便免疫化学検査（FIT）、グアヤクベース便潜血検査（gFOBT））、用途別市場規模（病院、専門クリニック、外来手術センター、診断センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・非侵襲的大腸がんスクリーニングの市場動向 ・企業の競争状況、市場シェア ・非侵襲的大腸がんスクリーニングの種類別市場規模と予測2016-2027（糞便免疫化学検査（FIT）、グアヤクベース便潜血検査（gFOBT）） ・非侵襲的大腸がんスクリーニングの用途別市場規模と予測2016-2027（病院、専門クリニック、外来手術センター、診断センター、その他） ・非侵襲的大腸がんスクリーニングの北米市場規模2016-2027（アメリカ、カナダ） ・非侵襲的大腸がんスクリーニングの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・非侵襲的大腸がんスクリーニングのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・非侵襲的大腸がんスクリーニングの中南米市場規模2016-2027（メキシコ、ブラジル） ・非侵襲的大腸がんスクリーニングの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、Beckman Coulter, Inc.、Epigenomics AG、Sysmex Corporation、Quest Diagnostics、Exact Sciences Corporation、Novigenix SA、CML Healthcare, Inc.） ・結論 |
Market Analysis and Insights: Global Non Invasive Colon Cancer Screening Market
The global Non Invasive Colon Cancer Screening market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Non Invasive Colon Cancer Screening market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Non Invasive Colon Cancer Screening market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Non Invasive Colon Cancer Screening market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Non Invasive Colon Cancer Screening market.
Global Non Invasive Colon Cancer Screening Scope and Market Size
Non Invasive Colon Cancer Screening market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Non Invasive Colon Cancer Screening market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Fecal Immunochemical Test (FIT)
Guaiac-based Fecal Occult Blood Test (gFOBT)
Segment by Application
Hospitals
Speciality Clinics
Ambulatory Surgical Centers
Diagnostic Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
Beckman Coulter, Inc.
Epigenomics AG
Sysmex Corporation
Quest Diagnostics
Exact Sciences Corporation
Novigenix SA
CML Healthcare, Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non Invasive Colon Cancer Screening Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Fecal Immunochemical Test (FIT)
1.2.3 Guaiac-based Fecal Occult Blood Test (gFOBT)
1.3 Market by Application
1.3.1 Global Non Invasive Colon Cancer Screening Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Speciality Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Diagnostic Centers
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Non Invasive Colon Cancer Screening Market Perspective (2016-2027)
2.2 Non Invasive Colon Cancer Screening Growth Trends by Regions
2.2.1 Non Invasive Colon Cancer Screening Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Non Invasive Colon Cancer Screening Historic Market Share by Regions (2016-2021)
2.2.3 Non Invasive Colon Cancer Screening Forecasted Market Size by Regions (2022-2027)
2.3 Non Invasive Colon Cancer Screening Industry Dynamic
2.3.1 Non Invasive Colon Cancer Screening Market Trends
2.3.2 Non Invasive Colon Cancer Screening Market Drivers
2.3.3 Non Invasive Colon Cancer Screening Market Challenges
2.3.4 Non Invasive Colon Cancer Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non Invasive Colon Cancer Screening Players by Revenue
3.1.1 Global Top Non Invasive Colon Cancer Screening Players by Revenue (2016-2021)
3.1.2 Global Non Invasive Colon Cancer Screening Revenue Market Share by Players (2016-2021)
3.2 Global Non Invasive Colon Cancer Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Non Invasive Colon Cancer Screening Revenue
3.4 Global Non Invasive Colon Cancer Screening Market Concentration Ratio
3.4.1 Global Non Invasive Colon Cancer Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non Invasive Colon Cancer Screening Revenue in 2020
3.5 Non Invasive Colon Cancer Screening Key Players Head office and Area Served
3.6 Key Players Non Invasive Colon Cancer Screening Product Solution and Service
3.7 Date of Enter into Non Invasive Colon Cancer Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non Invasive Colon Cancer Screening Breakdown Data by Type
4.1 Global Non Invasive Colon Cancer Screening Historic Market Size by Type (2016-2021)
4.2 Global Non Invasive Colon Cancer Screening Forecasted Market Size by Type (2022-2027)
5 Non Invasive Colon Cancer Screening Breakdown Data by Application
5.1 Global Non Invasive Colon Cancer Screening Historic Market Size by Application (2016-2021)
5.2 Global Non Invasive Colon Cancer Screening Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Non Invasive Colon Cancer Screening Market Size (2016-2027)
6.2 North America Non Invasive Colon Cancer Screening Market Size by Type
6.2.1 North America Non Invasive Colon Cancer Screening Market Size by Type (2016-2021)
6.2.2 North America Non Invasive Colon Cancer Screening Market Size by Type (2022-2027)
6.2.3 North America Non Invasive Colon Cancer Screening Market Size by Type (2016-2027)
6.3 North America Non Invasive Colon Cancer Screening Market Size by Application
6.3.1 North America Non Invasive Colon Cancer Screening Market Size by Application (2016-2021)
6.3.2 North America Non Invasive Colon Cancer Screening Market Size by Application (2022-2027)
6.3.3 North America Non Invasive Colon Cancer Screening Market Size by Application (2016-2027)
6.4 North America Non Invasive Colon Cancer Screening Market Size by Country
6.4.1 North America Non Invasive Colon Cancer Screening Market Size by Country (2016-2021)
6.4.2 North America Non Invasive Colon Cancer Screening Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Non Invasive Colon Cancer Screening Market Size (2016-2027)
7.2 Europe Non Invasive Colon Cancer Screening Market Size by Type
7.2.1 Europe Non Invasive Colon Cancer Screening Market Size by Type (2016-2021)
7.2.2 Europe Non Invasive Colon Cancer Screening Market Size by Type (2022-2027)
7.2.3 Europe Non Invasive Colon Cancer Screening Market Size by Type (2016-2027)
7.3 Europe Non Invasive Colon Cancer Screening Market Size by Application
7.3.1 Europe Non Invasive Colon Cancer Screening Market Size by Application (2016-2021)
7.3.2 Europe Non Invasive Colon Cancer Screening Market Size by Application (2022-2027)
7.3.3 Europe Non Invasive Colon Cancer Screening Market Size by Application (2016-2027)
7.4 Europe Non Invasive Colon Cancer Screening Market Size by Country
7.4.1 Europe Non Invasive Colon Cancer Screening Market Size by Country (2016-2021)
7.4.2 Europe Non Invasive Colon Cancer Screening Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Non Invasive Colon Cancer Screening Market Size (2016-2027)
8.2 Asia-Pacific Non Invasive Colon Cancer Screening Market Size by Type
8.2.1 Asia-Pacific Non Invasive Colon Cancer Screening Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Non Invasive Colon Cancer Screening Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Non Invasive Colon Cancer Screening Market Size by Type (2016-2027)
8.3 Asia-Pacific Non Invasive Colon Cancer Screening Market Size by Application
8.3.1 Asia-Pacific Non Invasive Colon Cancer Screening Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Non Invasive Colon Cancer Screening Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Non Invasive Colon Cancer Screening Market Size by Application (2016-2027)
8.4 Asia-Pacific Non Invasive Colon Cancer Screening Market Size by Region
8.4.1 Asia-Pacific Non Invasive Colon Cancer Screening Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Non Invasive Colon Cancer Screening Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Non Invasive Colon Cancer Screening Market Size (2016-2027)
9.2 Latin America Non Invasive Colon Cancer Screening Market Size by Type
9.2.1 Latin America Non Invasive Colon Cancer Screening Market Size by Type (2016-2021)
9.2.2 Latin America Non Invasive Colon Cancer Screening Market Size by Type (2022-2027)
9.2.3 Latin America Non Invasive Colon Cancer Screening Market Size by Type (2016-2027)
9.3 Latin America Non Invasive Colon Cancer Screening Market Size by Application
9.3.1 Latin America Non Invasive Colon Cancer Screening Market Size by Application (2016-2021)
9.3.2 Latin America Non Invasive Colon Cancer Screening Market Size by Application (2022-2027)
9.3.3 Latin America Non Invasive Colon Cancer Screening Market Size by Application (2016-2027)
9.4 Latin America Non Invasive Colon Cancer Screening Market Size by Country
9.4.1 Latin America Non Invasive Colon Cancer Screening Market Size by Country (2016-2021)
9.4.2 Latin America Non Invasive Colon Cancer Screening Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non Invasive Colon Cancer Screening Market Size (2016-2027)
10.2 Middle East & Africa Non Invasive Colon Cancer Screening Market Size by Type
10.2.1 Middle East & Africa Non Invasive Colon Cancer Screening Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Non Invasive Colon Cancer Screening Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Non Invasive Colon Cancer Screening Market Size by Type (2016-2027)
10.3 Middle East & Africa Non Invasive Colon Cancer Screening Market Size by Application
10.3.1 Middle East & Africa Non Invasive Colon Cancer Screening Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Non Invasive Colon Cancer Screening Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Non Invasive Colon Cancer Screening Market Size by Application (2016-2027)
10.4 Middle East & Africa Non Invasive Colon Cancer Screening Market Size by Country
10.4.1 Middle East & Africa Non Invasive Colon Cancer Screening Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Non Invasive Colon Cancer Screening Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Non Invasive Colon Cancer Screening Introduction
11.1.4 Abbott Laboratories Revenue in Non Invasive Colon Cancer Screening Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Beckman Coulter, Inc.
11.2.1 Beckman Coulter, Inc. Company Details
11.2.2 Beckman Coulter, Inc. Business Overview
11.2.3 Beckman Coulter, Inc. Non Invasive Colon Cancer Screening Introduction
11.2.4 Beckman Coulter, Inc. Revenue in Non Invasive Colon Cancer Screening Business (2016-2021)
11.2.5 Beckman Coulter, Inc. Recent Development
11.3 Epigenomics AG
11.3.1 Epigenomics AG Company Details
11.3.2 Epigenomics AG Business Overview
11.3.3 Epigenomics AG Non Invasive Colon Cancer Screening Introduction
11.3.4 Epigenomics AG Revenue in Non Invasive Colon Cancer Screening Business (2016-2021)
11.3.5 Epigenomics AG Recent Development
11.4 Sysmex Corporation
11.4.1 Sysmex Corporation Company Details
11.4.2 Sysmex Corporation Business Overview
11.4.3 Sysmex Corporation Non Invasive Colon Cancer Screening Introduction
11.4.4 Sysmex Corporation Revenue in Non Invasive Colon Cancer Screening Business (2016-2021)
11.4.5 Sysmex Corporation Recent Development
11.5 Quest Diagnostics
11.5.1 Quest Diagnostics Company Details
11.5.2 Quest Diagnostics Business Overview
11.5.3 Quest Diagnostics Non Invasive Colon Cancer Screening Introduction
11.5.4 Quest Diagnostics Revenue in Non Invasive Colon Cancer Screening Business (2016-2021)
11.5.5 Quest Diagnostics Recent Development
11.6 Exact Sciences Corporation
11.6.1 Exact Sciences Corporation Company Details
11.6.2 Exact Sciences Corporation Business Overview
11.6.3 Exact Sciences Corporation Non Invasive Colon Cancer Screening Introduction
11.6.4 Exact Sciences Corporation Revenue in Non Invasive Colon Cancer Screening Business (2016-2021)
11.6.5 Exact Sciences Corporation Recent Development
11.7 Novigenix SA
11.7.1 Novigenix SA Company Details
11.7.2 Novigenix SA Business Overview
11.7.3 Novigenix SA Non Invasive Colon Cancer Screening Introduction
11.7.4 Novigenix SA Revenue in Non Invasive Colon Cancer Screening Business (2016-2021)
11.7.5 Novigenix SA Recent Development
11.8 CML Healthcare, Inc.
11.8.1 CML Healthcare, Inc. Company Details
11.8.2 CML Healthcare, Inc. Business Overview
11.8.3 CML Healthcare, Inc. Non Invasive Colon Cancer Screening Introduction
11.8.4 CML Healthcare, Inc. Revenue in Non Invasive Colon Cancer Screening Business (2016-2021)
11.8.5 CML Healthcare, Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Non Invasive Colon Cancer Screening Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Fecal Immunochemical Test (FIT)
Table 3. Key Players of Guaiac-based Fecal Occult Blood Test (gFOBT)
Table 4. Global Non Invasive Colon Cancer Screening Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Non Invasive Colon Cancer Screening Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Non Invasive Colon Cancer Screening Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Non Invasive Colon Cancer Screening Market Share by Regions (2016-2021)
Table 8. Global Non Invasive Colon Cancer Screening Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Non Invasive Colon Cancer Screening Market Share by Regions (2022-2027)
Table 10. Non Invasive Colon Cancer Screening Market Trends
Table 11. Non Invasive Colon Cancer Screening Market Drivers
Table 12. Non Invasive Colon Cancer Screening Market Challenges
Table 13. Non Invasive Colon Cancer Screening Market Restraints
Table 14. Global Non Invasive Colon Cancer Screening Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Non Invasive Colon Cancer Screening Market Share by Players (2016-2021)
Table 16. Global Top Non Invasive Colon Cancer Screening Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non Invasive Colon Cancer Screening as of 2020)
Table 17. Ranking of Global Top Non Invasive Colon Cancer Screening Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Non Invasive Colon Cancer Screening Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Non Invasive Colon Cancer Screening Product Solution and Service
Table 21. Date of Enter into Non Invasive Colon Cancer Screening Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Non Invasive Colon Cancer Screening Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Non Invasive Colon Cancer Screening Revenue Market Share by Type (2016-2021)
Table 25. Global Non Invasive Colon Cancer Screening Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Non Invasive Colon Cancer Screening Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Non Invasive Colon Cancer Screening Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Non Invasive Colon Cancer Screening Revenue Market Share by Application (2016-2021)
Table 29. Global Non Invasive Colon Cancer Screening Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Non Invasive Colon Cancer Screening Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Non Invasive Colon Cancer Screening Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Non Invasive Colon Cancer Screening Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Non Invasive Colon Cancer Screening Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Non Invasive Colon Cancer Screening Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Non Invasive Colon Cancer Screening Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Non Invasive Colon Cancer Screening Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Non Invasive Colon Cancer Screening Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Non Invasive Colon Cancer Screening Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Non Invasive Colon Cancer Screening Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Non Invasive Colon Cancer Screening Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Non Invasive Colon Cancer Screening Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Non Invasive Colon Cancer Screening Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Non Invasive Colon Cancer Screening Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Non Invasive Colon Cancer Screening Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Non Invasive Colon Cancer Screening Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Non Invasive Colon Cancer Screening Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Non Invasive Colon Cancer Screening Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Non Invasive Colon Cancer Screening Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Non Invasive Colon Cancer Screening Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Non Invasive Colon Cancer Screening Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Non Invasive Colon Cancer Screening Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Non Invasive Colon Cancer Screening Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Non Invasive Colon Cancer Screening Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Non Invasive Colon Cancer Screening Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Non Invasive Colon Cancer Screening Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Non Invasive Colon Cancer Screening Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Non Invasive Colon Cancer Screening Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Non Invasive Colon Cancer Screening Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Non Invasive Colon Cancer Screening Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Non Invasive Colon Cancer Screening Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott Laboratories Company Details
Table 62. Abbott Laboratories Business Overview
Table 63. Abbott Laboratories Non Invasive Colon Cancer Screening Product
Table 64. Abbott Laboratories Revenue in Non Invasive Colon Cancer Screening Business (2016-2021) & (US$ Million)
Table 65. Abbott Laboratories Recent Development
Table 66. Beckman Coulter, Inc. Company Details
Table 67. Beckman Coulter, Inc. Business Overview
Table 68. Beckman Coulter, Inc. Non Invasive Colon Cancer Screening Product
Table 69. Beckman Coulter, Inc. Revenue in Non Invasive Colon Cancer Screening Business (2016-2021) & (US$ Million)
Table 70. Beckman Coulter, Inc. Recent Development
Table 71. Epigenomics AG Company Details
Table 72. Epigenomics AG Business Overview
Table 73. Epigenomics AG Non Invasive Colon Cancer Screening Product
Table 74. Epigenomics AG Revenue in Non Invasive Colon Cancer Screening Business (2016-2021) & (US$ Million)
Table 75. Epigenomics AG Recent Development
Table 76. Sysmex Corporation Company Details
Table 77. Sysmex Corporation Business Overview
Table 78. Sysmex Corporation Non Invasive Colon Cancer Screening Product
Table 79. Sysmex Corporation Revenue in Non Invasive Colon Cancer Screening Business (2016-2021) & (US$ Million)
Table 80. Sysmex Corporation Recent Development
Table 81. Quest Diagnostics Company Details
Table 82. Quest Diagnostics Business Overview
Table 83. Quest Diagnostics Non Invasive Colon Cancer Screening Product
Table 84. Quest Diagnostics Revenue in Non Invasive Colon Cancer Screening Business (2016-2021) & (US$ Million)
Table 85. Quest Diagnostics Recent Development
Table 86. Exact Sciences Corporation Company Details
Table 87. Exact Sciences Corporation Business Overview
Table 88. Exact Sciences Corporation Non Invasive Colon Cancer Screening Product
Table 89. Exact Sciences Corporation Revenue in Non Invasive Colon Cancer Screening Business (2016-2021) & (US$ Million)
Table 90. Exact Sciences Corporation Recent Development
Table 91. Novigenix SA Company Details
Table 92. Novigenix SA Business Overview
Table 93. Novigenix SA Non Invasive Colon Cancer Screening Product
Table 94. Novigenix SA Revenue in Non Invasive Colon Cancer Screening Business (2016-2021) & (US$ Million)
Table 95. Novigenix SA Recent Development
Table 96. CML Healthcare, Inc. Company Details
Table 97. CML Healthcare, Inc. Business Overview
Table 98. CML Healthcare, Inc. Revenue in Non Invasive Colon Cancer Screening Business (2016-2021) & (US$ Million)
Table 99. CML Healthcare, Inc. Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non Invasive Colon Cancer Screening Market Share by Type: 2020 VS 2027
Figure 2. Fecal Immunochemical Test (FIT) Features
Figure 3. Guaiac-based Fecal Occult Blood Test (gFOBT) Features
Figure 4. Global Non Invasive Colon Cancer Screening Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Speciality Clinics Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Non Invasive Colon Cancer Screening Report Years Considered
Figure 11. Global Non Invasive Colon Cancer Screening Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Non Invasive Colon Cancer Screening Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Non Invasive Colon Cancer Screening Market Share by Regions: 2020 VS 2027
Figure 14. Global Non Invasive Colon Cancer Screening Market Share by Regions (2022-2027)
Figure 15. Global Non Invasive Colon Cancer Screening Market Share by Players in 2020
Figure 16. Global Top Non Invasive Colon Cancer Screening Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non Invasive Colon Cancer Screening as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Non Invasive Colon Cancer Screening Revenue in 2020
Figure 18. Global Non Invasive Colon Cancer Screening Revenue Market Share by Type (2016-2021)
Figure 19. Global Non Invasive Colon Cancer Screening Revenue Market Share by Type (2022-2027)
Figure 20. North America Non Invasive Colon Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Non Invasive Colon Cancer Screening Market Share by Type (2016-2027)
Figure 22. North America Non Invasive Colon Cancer Screening Market Share by Application (2016-2027)
Figure 23. North America Non Invasive Colon Cancer Screening Market Share by Country (2016-2027)
Figure 24. United States Non Invasive Colon Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Non Invasive Colon Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Non Invasive Colon Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Non Invasive Colon Cancer Screening Market Share by Type (2016-2027)
Figure 28. Europe Non Invasive Colon Cancer Screening Market Share by Application (2016-2027)
Figure 29. Europe Non Invasive Colon Cancer Screening Market Share by Country (2016-2027)
Figure 30. Germany Non Invasive Colon Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Non Invasive Colon Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Non Invasive Colon Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Non Invasive Colon Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Non Invasive Colon Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Non Invasive Colon Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Non Invasive Colon Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Non Invasive Colon Cancer Screening Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Non Invasive Colon Cancer Screening Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Non Invasive Colon Cancer Screening Market Share by Region (2016-2027)
Figure 40. China Non Invasive Colon Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Non Invasive Colon Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Non Invasive Colon Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Non Invasive Colon Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Non Invasive Colon Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Non Invasive Colon Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Non Invasive Colon Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Non Invasive Colon Cancer Screening Market Share by Type (2016-2027)
Figure 48. Latin America Non Invasive Colon Cancer Screening Market Share by Application (2016-2027)
Figure 49. Latin America Non Invasive Colon Cancer Screening Market Share by Country (2016-2027)
Figure 50. Mexico Non Invasive Colon Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Non Invasive Colon Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Non Invasive Colon Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Non Invasive Colon Cancer Screening Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Non Invasive Colon Cancer Screening Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Non Invasive Colon Cancer Screening Market Share by Country (2016-2027)
Figure 56. Turkey Non Invasive Colon Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Non Invasive Colon Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Non Invasive Colon Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Abbott Laboratories Revenue Growth Rate in Non Invasive Colon Cancer Screening Business (2016-2021)
Figure 60. Beckman Coulter, Inc. Revenue Growth Rate in Non Invasive Colon Cancer Screening Business (2016-2021)
Figure 61. Epigenomics AG Revenue Growth Rate in Non Invasive Colon Cancer Screening Business (2016-2021)
Figure 62. Sysmex Corporation Revenue Growth Rate in Non Invasive Colon Cancer Screening Business (2016-2021)
Figure 63. Quest Diagnostics Revenue Growth Rate in Non Invasive Colon Cancer Screening Business (2016-2021)
Figure 64. Exact Sciences Corporation Revenue Growth Rate in Non Invasive Colon Cancer Screening Business (2016-2021)
Figure 65. Novigenix SA Revenue Growth Rate in Non Invasive Colon Cancer Screening Business (2016-2021)
Figure 66. CML Healthcare, Inc. Revenue Growth Rate in Non Invasive Colon Cancer Screening Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
世界の糞便免疫化学的診断検査市場規模・現状・予測（2021年-2027年） In a fecal immunochemical diagnostic test, antibodies are used to detect blood in the stool, which bind to a blood protein called hemoglobin found in red blood cells (RBC). A positive result of a fecal immunochemical diagnostic test may be a sign of colorectal cancer, polyps, ulcers or hemorrhoids. …- 大腸がん迅速検査キットのグローバル市場調査 2019年 The global Colon Cancer Rapid Test Kit market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Colon Cancer Rapid Test Kit volume and value at global level, regional level and company level. From a global p…
- 世界の結腸がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing colon cancer Market Analysis and Insights: Global Colon Cancer Molecular Diagnostics Market The global Colon Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With…
- 世界の非侵襲的非経口スクリーニング市場規模・現状・予測（2021年-2027年） Non-invasive Parenteral Screening is a nascent genetic process of examining a fetal cell free DNA present in the mothers blood serum for detecting common fetal aneuploidies. Its main objective is early detection of genetic disorders such as trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), t…
- 世界の乳がん再発スコア検査市場規模・現状・予測（2021年-2027年） The breast cancer recurrence score test is a genomic test that extracts breast cancer tissue during surgery to check the activity of certain genes related to breast cancer, which is very helpful for the treatment of breast cancer. In addition, the breast cancer recurrence score test can also estimat…